A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma

Indian Journal of Dermatology, Venereology and Leprology

Volumn 78, Issue 2, 2012, Pages 165-171

  Kar, Hemanta Kumar ^a   Gupta, Lipy ^a   Chauhan, Amrita ^a  

^a DR RAM MANOHAR LOHIA HOSPITAL   (India)

Author keywords

Glycolic acid peel; low fluence Q switched Nd:YAG laser; melasma

Indexed keywords

BICARBONATE; GLYCOLIC ACID; LIDOCAINE; LOCAL ANESTHETIC AGENT; PRILOCAINE; RETINOIC ACID; SUNSCREEN;

ADULT; ARTICLE; ASIAN; BURNING SENSATION; CHEEK; CHEMICAL PEEL; CHLOASMA; COMPARATIVE STUDY; DERMATOLOGICAL PROCEDURES; DISEASE SEVERITY; ERYTHEMA; ETHNIC GROUP; EYE PROTECTION; FACE; FACE EDEMA; FEMALE; FOLLOW UP; FOREHEAD; HUMAN; HYPERPIGMENTATION; INDIA; INFLAMMATION; LOW FLUENCE Q SWITCHED NEODYMIUM LASER; MAJOR CLINICAL STUDY; MALE; MEDICAL TECHNOLOGY; MELASMA AREA AND SEVERITY INDEX; NEODYMIUM LASER; NOSE; PROTECTIVE EQUIPMENT; SCORING SYSTEM; SKIN BIOPSY; SKIN PIGMENTATION; SPECTACLES; TREATMENT INDICATION; TREATMENT OUTCOME; UPPER LIP;

ADULT; CHEMEXFOLIATION; FEMALE; GLYCOLATES; HUMANS; KERATOLYTIC AGENTS; LASER THERAPY, LOW-LEVEL; LASERS, SOLID-STATE; MALE; MELANOSIS; MIDDLE AGED; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859310985     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.93633     Document Type: Article

References (24)

1. Grimes PE. Melasma: Etiologic and therapeutic considerations. Arch Dermatol 1995;131:1453-7.
2. Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC Jr. Melasma: A clinical, light microscopic, ultra structural, and immunofluorescence study. J Am Acad Dermatol 1981;4:698-710.
3. Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, et al. Melasma: Histopathological characteristics in 56 Korean patients. Br J Dermatol 2002;146:228-37.
4. Pasricha JS, Khaitan BK, Dash S. Pigmentary disorders in India. Dermatol Clin 2007;25:343-52.
5. Vázquez M, Maldonado H, Benmamán C, Sánchez JL. Melasma in men: A clinical and histological study. Int J Dermatol 1988;27:25-7.
6. Pérez M, Sánchez JL, Aguiló F. Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol 1983;81:543-5.
7. Grimes PE, Yamada N, Bhawan J. Light microscopic, immunohistochemical and ultrastructural alteration in patients with melasma. Am J Dermatopath 2005;27:96-101.
8. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: A review of clinical trials. J Am Acad Dermatol 2006;55:1048-65.
9. Palumbo A, d'Ischia M, Misuraca G, Prota G. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta 1991;1073:85-90.
10. Ferreira Cestari T, Hassun K, Sittart A, de Lourdes Viegas M. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate severe facial melasma. J Cosmet Dermatol 2007;6:36-9.
11. Lipper GM, Anderson RR. Lasers in dermatology. In. Freedburg IM, Eisen AZ, Wolf Ketal, editors. Fitzpatrick dermatology in general medicine. 7th ed. New York: McGraw Hill; 2007. p. 2508.
12. Pandya A, Berneburg M, Ortonne JP, Picardo M. Guidelines for clinical trials in melasma: Pigmentation disorders academy. Br J Dermatol 2006;156:21-8.
13. Javaheri SM, Handa S, Kaur I, Kumar B. Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol 2001;40:354-7.
14. Griffiths CE, Finkel LJ, Ditre CM, Hamilton TA, Ellis CN, Voorhees JJ. Topical tretinoin (retinoic acid) improves melasma: A vehiclecontrolled, clinical trial. Br J Dermatol 1993;129:415-21.
15. Sarkar R, Puri P, Jain RK, Singh A, Desai A. Melasma in men: A clinical, aetiological and histological study. J Eur Acad Dermatol Venereol 2010;24:768-72.
16. Anderson RR, Margolis RJ, Watenabe S, Flotte T, Hruza GJ, Dover JS. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol 1989;93:28-32.
17. Kurban AK, Morrison PR, Trainor SW, Tan OT. Pulse duration effects on cutaneous pigment. Lasers Surg Med 1992;12:282-7.
18. Polnikorn N, Tanrattanakorn S, Goldberg DJ. Treatment of Hori's nevus with the Q-switched Nd:YAG laser. Dermatol Surg 2000;26:477-80.
19. Polnikorn N. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: Two case reports. J Cosmet Laser Ther 2008;10:167-73.
20. Cho SB, Kim JS, Kim MJ. Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. Clin Exp Dermatol 2009;34:e847-50.
21. Suh KS, Sung JY, Roh HJ, Jeon YS, Kim YC, Kim ST. Efficacy of 1064 nm Q switched Nd:YAG Laser in melasma. J Dermatolog Treat;2011;22:233-8.
22. Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-Doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg 2010;36:76-87.
23. Khunger N. Glycolic acid peels. In: Khunger N, editor. Step by step chemical peels. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2009. p. 70-87.
24. Behl DS, Tung R. Chemical peels. In: Alam M, Gladstone HB, Tung RC, editors. Requisites in dermatology: Cosmetic dermatology (Vol. 1). Edinburgh: Elsevier Limited; 2009. p. 81-101.